Glioma Who

• CLINICAL_TRIALS trial_result · 2026-04-23
  Clinical Trial Update: Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment [Phase 2]

  A Phase 2 clinical trial is testing Erdafitinib for recurrent glioma (including WHO grades 2–4) that has progressed after prior treatment; r…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma [Phase 3]

  This clinical trial update describes a Phase 3 study comparing selumetinib alone to selumetinib plus vinblastine in patients with recurrent …

• CLINICAL_TRIALS other · 2026-04-13
  Clinical Trial Update: Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma [Phase 1]

  This clinical trial update describes a Phase 1 study evaluating the combination of Actimab-A and cemiplimab (REGN2810) for recurrent gliobla…